- GE shares surge 17% after Danaher agrees to buy biopharma business for $21.4 billionCNBC
- GE to sell BioPharma business to Danaher for $21.4BFox Business
- GE to Sell Its Biotech Business to Danaher for $21 BillionThe Wall Street Journal
- GE’s stock soars after deal to sell biopharma business to Danaher for $21.4 billionMarketWatch
- General Electric Sells Biopharma Unit for $21.4 Billion as Culp Unwind ContinuesTheStreet.com
- View full coverage on Google News